ArticleACR open rheumatology2024

Safety, Tolerability, and Pharmacodynamics of the ADAMTS-5 Nanobody M6495: Two Phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled Studies in Healthy Subjects and Patients With Osteoarthritis.

Asger Reinstrup Bihlet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.